Article
CD33 targeted EzH1 regulated nanotherapy epigenetically inhibits fusion oncoprotein (AML1-ETO) rearranged acute myeloid leukemia in both in vitro and in vivo Patient Derived Xenograft models
2024-11-14
Abstract excerpt
No abstract is available from the source.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c4d45949-c433-5474-a8d5-27d88e1fd388
- DOI
- 10.1016/j.nantod.2024.102542
